Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
View ORCID ProfileP.J. Ducrest
doi: https://doi.org/10.1101/2020.10.09.20209866
P.J. Ducrest
1GaDia SA, Route de l’ile au bois 1A, 1870 Monthey, Switzerland
Posted October 13, 2020.
Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
P.J. Ducrest
medRxiv 2020.10.09.20209866; doi: https://doi.org/10.1101/2020.10.09.20209866
Subject Area
Subject Areas
- Addiction Medicine (325)
- Allergy and Immunology (637)
- Anesthesia (169)
- Cardiovascular Medicine (2424)
- Dermatology (208)
- Emergency Medicine (382)
- Epidemiology (11852)
- Forensic Medicine (10)
- Gastroenterology (706)
- Genetic and Genomic Medicine (3805)
- Geriatric Medicine (353)
- Health Economics (642)
- Health Informatics (2441)
- Health Policy (944)
- Hematology (345)
- HIV/AIDS (799)
- Medical Education (374)
- Medical Ethics (105)
- Nephrology (406)
- Neurology (3560)
- Nursing (201)
- Nutrition (534)
- Oncology (1846)
- Ophthalmology (542)
- Orthopedics (224)
- Otolaryngology (291)
- Pain Medicine (234)
- Palliative Medicine (68)
- Pathology (452)
- Pediatrics (1048)
- Primary Care Research (425)
- Public and Global Health (6223)
- Radiology and Imaging (1305)
- Respiratory Medicine (840)
- Rheumatology (383)
- Sports Medicine (328)
- Surgery (412)
- Toxicology (51)
- Transplantation (174)
- Urology (148)